Matthew Wilson
Last active: 3/24/2020

  1. Genome Engineering Renal Epithelial Cells for Enhanced Volume Transport Function. Wilson MH, Veach RA, Luo W, Welch RC, Roy S, Fissell WH (2020) Cell Mol Bioeng 13(1): 17-26
    › Primary publication · 32030105 (PubMed) · PMC6981331 (PubMed Central)
  2. CRISPR/Cas9 engineering of albino cystinuria Type A mice. Beckermann TM, Welch RC, Williams FM, Mortlock DP, Sha F, Ikizler TA, Woodard LE, Wilson MH (2020) Genesis 58(5): e23357
    › Primary publication · 32078250 (PubMed) · PMC7781090 (PubMed Central)
  3. Metabolic consequences of cystinuria. Woodard LE, Welch RC, Veach RA, Beckermann TM, Sha F, Weinman EJ, Ikizler TA, Tischfield JA, Sahota A, Wilson MH (2019) BMC Nephrol 20(1): 227
    › Primary publication · 31221135 (PubMed) · PMC6585015 (PubMed Central)
  4. Direct reprogramming to human nephron progenitor-like cells using inducible piggyBac transposon expression of SNAI2-EYA1-SIX1. Vanslambrouck JM, Woodard LE, Suhaimi N, Williams FM, Howden SE, Wilson SB, Lonsdale A, Er PX, Li J, Maksimovic J, Oshlack A, Wilson MH, Little MH (2019) Kidney Int 95(5): 1153-1166
    › Primary publication · 30827514 (PubMed) · PMC6478531 (PubMed Central)
  5. Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo. O'Neil RT, Saha S, Veach RA, Welch RC, Woodard LE, Rooney CM, Wilson MH (2018) Nat Commun 9(1): 1325
    › Primary publication · 29636469 (PubMed) · PMC5893599 (PubMed Central)
  6. Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR. Hamada M, Nishio N, Okuno Y, Suzuki S, Kawashima N, Muramatsu H, Tsubota S, Wilson MH, Morita D, Kataoka S, Ichikawa D, Murakami N, Taniguchi R, Suzuki K, Kojima D, Sekiya Y, Nishikawa E, Narita A, Hama A, Kojima S, Nakazawa Y, Takahashi Y (2018) EBioMedicine : 18-26
    › Primary publication · 30082227 (PubMed) · PMC6116345 (PubMed Central)
  7. Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney. Woodard LE, Welch RC, Williams FM, Luo W, Cheng J, Wilson MH (2018) J Vis Exp (131)
    › Primary publication · 29364221 (PubMed) · PMC5907682 (PubMed Central)
  8. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in Transposon-Engineered T Cells. Morita D, Nishio N, Saito S, Tanaka M, Kawashima N, Okuno Y, Suzuki S, Matsuda K, Maeda Y, Wilson MH, Dotti G, Rooney CM, Takahashi Y, Nakazawa Y (2018) Mol Ther Methods Clin Dev : 131-140
    › Primary publication · 29687032 (PubMed) · PMC5907825 (PubMed Central)
  9. CRISPR/Cas9 engineering of a KIM-1 reporter human proximal tubule cell line. Veach RA, Wilson MH (2018) PLoS One 13(9): e0204487
    › Primary publication · 30260998 (PubMed) · PMC6160069 (PubMed Central)
  10. Consider Changing the Horse for Your CAR-T? Wilson MH (2018) Mol Ther 26(8): 1873-1874
    › Primary publication · 30078438 (PubMed) · PMC6094485 (PubMed Central)